{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:49:33Z","timestamp":1789948173389,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Macrophage infiltrations (inflammation) are associated with prostate disorders such as prostatitis, prostatic hyperplasia and prostate cancer. All prostate disorders have elevated cell proliferation, and are initiated from normal prostate epithelial cells. To date, the mechanism of how macrophages regulate normal prostate epithelial cell proliferation remains largely unknown. Using a 3D co-culture system, we here show that Raw 264.7 macrophages increased cell proliferation of normal prostate epithelial PZ-HPV-7 cells. In addition, these Raw 264.7 macrophages expressed higher levels of Ym1 and CD206. We further identify macrophage-secreted cytokines including CCL3, IL-1ra, osteopontin, M-CSF1 and GDNF as mediators for potentiating PZ-HPV-7 cell proliferation in 3D. All these cytokines differentially activated ERK and Akt. Blockade of both kinases through their inhibitors hindered macrophage-induced cell proliferation of PZ-HPV-7 cells. Hence, our data provide mechanistic insight of how inflammation may contribute to development of prostatic diseases at a very early stage through augment of cell proliferation of normal prostate epithelial cells.<\/jats:p>","DOI":"10.1038\/s41598-018-26143-8","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T14:51:24Z","timestamp":1525963884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt"],"prefix":"10.1038","volume":"8","author":[{"given":"Tu","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geou-Yarh","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"26143_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2353\/ajpath.2009.081107","volume":"175","author":"SJ Ellem","year":"2009","unstructured":"Ellem, S. J., Wang, H., Poutanen, M. & Risbridger, G. P. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 175, 1187\u20131199 (2009).","journal-title":"Am J Pathol"},{"key":"26143_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","volume":"84","author":"JC Nickel","year":"1999","unstructured":"Nickel, J. C., Downey, J., Young, I. & Boag, S. Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia. BJU Int 84, 976\u2013981 (1999).","journal-title":"BJU Int"},{"key":"26143_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2012","unstructured":"Sfanos, K. S. & De Marzo, A. M. Prostate cancer and inflammation: the evidence. Histopathology 60, 199\u2013215 (2012).","journal-title":"Histopathology"},{"key":"26143_CR4","first-page":"3","volume":"1","author":"KS Sfanos","year":"2013","unstructured":"Sfanos, K. S., Isaacs, W. B. & De Marzo, A. M. Infections and inflammation in prostate cancer. Am J Clin Exp Urol 1, 3\u201311 (2013).","journal-title":"Am J Clin Exp Urol"},{"key":"26143_CR5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/path.4472","volume":"235","author":"BW Simons","year":"2015","unstructured":"Simons, B. W. et al. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol 235, 478\u2013489 (2015).","journal-title":"J Pathol"},{"key":"26143_CR6","doi-asserted-by":"publisher","first-page":"18376","DOI":"10.1074\/jbc.M112.355164","volume":"287","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. J Biol Chem 287, 18376\u201318385 (2012).","journal-title":"J Biol Chem"},{"key":"26143_CR7","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/1097-0142(197805)41:5<1857::AID-CNCR2820410529>3.0.CO;2-T","volume":"41","author":"GB Dermer","year":"1978","unstructured":"Dermer, G. B. Basal cell proliferation in benign prostatic hyperplasia. Cancer 41, 1857\u20131862 (1978).","journal-title":"Cancer"},{"key":"26143_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1097-0045(19981201)37:4<223::AID-PROS3>3.0.CO;2-O","volume":"37","author":"MI Johnson","year":"1998","unstructured":"Johnson, M. I. et al. Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation. Prostate 37, 223\u2013229 (1998).","journal-title":"Prostate"},{"key":"26143_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/pros.23227","volume":"76","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell. Prostate 76, 1431\u20131444 (2016).","journal-title":"Prostate"},{"key":"26143_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ccr.2008.06.002","volume":"14","author":"PK Majumder","year":"2008","unstructured":"Majumder, P. K. et al. A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. Cancer Cell 14, 146\u2013155 (2008).","journal-title":"Cancer Cell"},{"key":"26143_CR11","first-page":"7415","volume":"50","author":"S Preston-Martin","year":"1990","unstructured":"Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A. & Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res 50, 7415\u20137421 (1990).","journal-title":"Cancer Res"},{"key":"26143_CR12","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1158\/0008-5472.CAN-05-4472","volume":"66","author":"Y Xu","year":"2006","unstructured":"Xu, Y., Chen, S. Y., Ross, K. N. & Balk, S. P. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 66, 7783\u20137792 (2006).","journal-title":"Cancer Res"},{"key":"26143_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"26143_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"26143_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","volume":"60","author":"C De Nunzio","year":"2011","unstructured":"De Nunzio, C. et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 60, 106\u2013117 (2011).","journal-title":"Eur Urol"},{"key":"26143_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/modpathol.2012.51","volume":"25","author":"ON Kryvenko","year":"2012","unstructured":"Kryvenko, O. N. et al. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 25, 1023\u20131032 (2012).","journal-title":"Mod Pathol"},{"key":"26143_CR17","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/01.ju.0000108131.43160.77","volume":"171","author":"EA Platz","year":"2004","unstructured":"Platz, E. A. & De Marzo, A. M. Epidemiology of inflammation and prostate cancer. J Urol 171, S36\u201340 (2004).","journal-title":"J Urol"},{"key":"26143_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman, P. H., Hoekx, L., Wyndaele, J. J., Jeuris, W. & Van Marck, E. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 37, 404\u2013412 (2000).","journal-title":"Eur Urol"},{"key":"26143_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.urology.2008.07.028","volume":"72","author":"T Terakawa","year":"2008","unstructured":"Terakawa, T. et al. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng\/mL. Urology 72, 1194\u20131197 (2008).","journal-title":"Urology"},{"key":"26143_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/bju.12153","volume":"112","author":"TH Yli-Hemminki","year":"2013","unstructured":"Yli-Hemminki, T. H. et al. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int 112, 735\u2013741 (2013).","journal-title":"BJU Int"},{"key":"26143_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","volume":"32","author":"CD Mills","year":"2012","unstructured":"Mills, C. D. M1 and M2 Macrophages: Oracles of Health and Disease. Crit Rev Immunol 32, 463\u2013488 (2012).","journal-title":"Crit Rev Immunol"},{"key":"26143_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122, 787\u2013795 (2012).","journal-title":"J Clin Invest"},{"key":"26143_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.14336\/AD.2014.050052","volume":"5","author":"I Afanas\u2019ev","year":"2014","unstructured":"Afanas\u2019ev, I. New nucleophilic mechanisms of ros-dependent epigenetic modifications: comparison of aging and cancer. Aging Dis 5, 52\u201362 (2014).","journal-title":"Aging Dis"},{"key":"26143_CR24","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/ijms12053117","volume":"12","author":"A Fernandez-Sanchez","year":"2011","unstructured":"Fernandez-Sanchez, A. et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 12, 3117\u20133132 (2011).","journal-title":"Int J Mol Sci"},{"key":"26143_CR25","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752\u20131761 (2004).","journal-title":"J Clin Invest"},{"key":"26143_CR26","doi-asserted-by":"crossref","unstructured":"Lim, S.O. et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 135, 2128-2140, 2140 e2121-2128 (2008).","DOI":"10.1053\/j.gastro.2008.07.027"},{"key":"26143_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic Res 44, 479\u2013496 (2010).","journal-title":"Free Radic Res"},{"key":"26143_CR28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jhep.2010.06.044","volume":"54","author":"G Vial","year":"2011","unstructured":"Vial, G. et al. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J Hepatol 54, 348\u2013356 (2011).","journal-title":"J Hepatol"},{"key":"26143_CR29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","volume":"15","author":"J MacMicking","year":"1997","unstructured":"MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function. Annu Rev Immunol 15, 323\u2013350 (1997).","journal-title":"Annu Rev Immunol"},{"key":"26143_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677\u2013686 (2004).","journal-title":"Trends Immunol"},{"key":"26143_CR31","doi-asserted-by":"publisher","first-page":"816460","DOI":"10.1155\/2015\/816460","volume":"2015","author":"T Roszer","year":"2015","unstructured":"Roszer, T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm 2015, 816460 (2015).","journal-title":"Mediators Inflamm"},{"key":"26143_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A. & Locati, M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229, 176\u2013185 (2013).","journal-title":"J Pathol"},{"key":"26143_CR33","doi-asserted-by":"publisher","first-page":"e10431","DOI":"10.1371\/journal.pone.0010431","volume":"5","author":"V Harma","year":"2010","unstructured":"Harma, V. et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5, e10431 (2010).","journal-title":"PLoS One"},{"key":"26143_CR34","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1128\/MCB.23.17.6139-6149.2003","volume":"23","author":"A Radu","year":"2003","unstructured":"Radu, A., Neubauer, V., Akagi, T., Hanafusa, H. & Georgescu, M. M. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 23, 6139\u20136149 (2003).","journal-title":"Mol Cell Biol"},{"key":"26143_CR35","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1161\/01.RES.0000049105.15329.1C","volume":"92","author":"M Tamamori-Adachi","year":"2003","unstructured":"Tamamori-Adachi, M. et al. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res 92, e12\u201319 (2003).","journal-title":"Circ Res"},{"key":"26143_CR36","doi-asserted-by":"crossref","unstructured":"Tong, W. & Pollard, J.W. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19, 2251-2264 (1999).","DOI":"10.1128\/MCB.19.3.2251"},{"key":"26143_CR37","doi-asserted-by":"publisher","first-page":"e0145342","DOI":"10.1371\/journal.pone.0145342","volume":"10","author":"KA Jablonski","year":"2015","unstructured":"Jablonski, K. A. et al. Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One 10, e0145342 (2015).","journal-title":"PLoS One"},{"key":"26143_CR38","doi-asserted-by":"publisher","first-page":"e24663","DOI":"10.1371\/journal.pone.0024663","volume":"6","author":"E Conte","year":"2011","unstructured":"Conte, E. et al. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. PLoS One 6, e24663 (2011).","journal-title":"PLoS One"},{"key":"26143_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35, 600\u2013604 (2015).","journal-title":"J Recept Signal Transduct Res"},{"key":"26143_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang, W. & Liu, H. T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12, 9\u201318 (2002).","journal-title":"Cell Res"},{"key":"26143_CR41","doi-asserted-by":"publisher","first-page":"476380","DOI":"10.1155\/2012\/476380","volume":"2012","author":"F Emanuela","year":"2012","unstructured":"Emanuela, F. et al. Inflammation as a Link between Obesity and Metabolic Syndrome. J Nutr Metab 2012, 476380 (2012).","journal-title":"J Nutr Metab"},{"key":"26143_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415\u2013445 (2011).","journal-title":"Annu Rev Immunol"},{"key":"26143_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.09.025","volume":"167","author":"Y Nedelec","year":"2016","unstructured":"Nedelec, Y. et al. Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens. Cell 167, 657\u2013669 e621 (2016).","journal-title":"Cell"},{"key":"26143_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2016.09.024","volume":"167","author":"H Quach","year":"2016","unstructured":"Quach, H. et al. Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations. Cell 167, 643\u2013656 e617 (2016).","journal-title":"Cell"},{"key":"26143_CR45","first-page":"130","volume":"3","author":"JA Woods","year":"2012","unstructured":"Woods, J. A., Wilund, K. R., Martin, S. A. & Kistler, B. M. Exercise, inflammation and aging. Aging Dis 3, 130\u2013140 (2012).","journal-title":"Aging Dis"},{"key":"26143_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-68","volume":"11","author":"CJ Hsu","year":"2013","unstructured":"Hsu, C. J. et al. AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma. Cell Commun Signal 11, 68 (2013).","journal-title":"Cell Commun Signal"},{"key":"26143_CR47","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.18632\/oncotarget.6708","volume":"7","author":"YY Liao","year":"2016","unstructured":"Liao, Y. Y. et al. CCL3 promotes angiogenesis by dysregulation of miR-374b\/ VEGF-A axis in human osteosarcoma cells. Oncotarget 7, 4310\u20134325 (2016).","journal-title":"Oncotarget"},{"key":"26143_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11010-010-0617-0","volume":"347","author":"H Liu","year":"2011","unstructured":"Liu, H., Ma, Q. & Li, J. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem 347, 95\u2013101 (2011).","journal-title":"Mol Cell Biochem"},{"key":"26143_CR49","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.4049\/jimmunol.174.12.7531","volume":"174","author":"T Okazaki","year":"2005","unstructured":"Okazaki, T. et al. Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis. J Immunol 174, 7531\u20137538 (2005).","journal-title":"J Immunol"},{"key":"26143_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.matbio.2014.03.001","volume":"37","author":"LA Shevde","year":"2014","unstructured":"Shevde, L. A. & Samant, R. S. Role of osteopontin in the pathophysiology of cancer. Matrix Biol 37, 131\u2013141 (2014).","journal-title":"Matrix Biol"},{"key":"26143_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neures.2006.04.019","volume":"56","author":"H Song","year":"2006","unstructured":"Song, H. & Moon, A. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1\/2 and p38 MAPK signaling pathways. Neurosci Res 56, 29\u201338 (2006).","journal-title":"Neurosci Res"},{"key":"26143_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10555-007-9104-9","volume":"27","author":"PY Wai","year":"2008","unstructured":"Wai, P. Y. & Kuo, P. C. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 27, 103\u2013118 (2008).","journal-title":"Cancer Metastasis Rev"},{"key":"26143_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4161\/cbt.19237","volume":"13","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells. Cancer Biol Ther 13, 389\u2013400 (2012).","journal-title":"Cancer Biol Ther"},{"key":"26143_CR54","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.celrep.2017.04.052","volume":"19","author":"GY Liou","year":"2017","unstructured":"Liou, G. Y. et al. The Presence of Interleukin-13 at Pancreatic ADM\/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis. Cell Rep 19, 1322\u20131333 (2017).","journal-title":"Cell Rep"},{"key":"26143_CR55","doi-asserted-by":"publisher","first-page":"R580","DOI":"10.1152\/ajpregu.00240.2012","volume":"303","author":"ML Quick","year":"2012","unstructured":"Quick, M. L. et al. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol 303, R580\u2013589 (2012).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"26143_CR56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nature13638","volume":"515","author":"D Di Mitri","year":"2014","unstructured":"Di Mitri, D. et al. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature 515, 134\u2013137 (2014).","journal-title":"Nature"},{"key":"26143_CR57","doi-asserted-by":"publisher","first-page":"16476","DOI":"10.1074\/jbc.M112.448142","volume":"288","author":"DR Yang","year":"2013","unstructured":"Yang, D. R. et al. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+stem\/progenitor cells to battle prostate cancer. J Biol Chem 288, 16476\u201316483 (2013).","journal-title":"J Biol Chem"},{"key":"26143_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1097-0045(19980501)35:2<83::AID-PROS1>3.0.CO;2-H","volume":"35","author":"A Elgavish","year":"1998","unstructured":"Elgavish, A. et al. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate 35, 83\u201394 (1998).","journal-title":"Prostate"},{"key":"26143_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.ATV.13.1.120","volume":"13","author":"AP Gadeau","year":"1993","unstructured":"Gadeau, A. P., Campan, M., Millet, D., Candresse, T. & Desgranges, C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 13, 120\u2013125 (1993).","journal-title":"Arterioscler Thromb"},{"key":"26143_CR60","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1074\/jbc.M706712200","volume":"283","author":"JA Kang","year":"2008","unstructured":"Kang, J. A. et al. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J Biol Chem 283, 6997\u20137006 (2008).","journal-title":"J Biol Chem"},{"key":"26143_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13287-015-0098-x","volume":"6","author":"M Rabenstein","year":"2015","unstructured":"Rabenstein, M. et al. Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4. Stem Cell Res Ther 6, 99 (2015).","journal-title":"Stem Cell Res Ther"},{"key":"26143_CR62","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1023\/A:1025419708343","volume":"20","author":"G Carlinfante","year":"2003","unstructured":"Carlinfante, G. et al. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis 20, 437\u2013444 (2003).","journal-title":"Clin Exp Metastasis"},{"key":"26143_CR63","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<246::AID-PROS5>3.0.CO;2-U","volume":"39","author":"KS Koeneman","year":"1999","unstructured":"Koeneman, K. S., Yeung, F. & Chung, L. W. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 39, 246\u2013261 (1999).","journal-title":"Prostate"},{"key":"26143_CR64","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/ijc.21619","volume":"118","author":"SS Forootan","year":"2006","unstructured":"Forootan, S. S. et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 118, 2255\u20132261 (2006).","journal-title":"Int J Cancer"},{"key":"26143_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/pros.20008","volume":"59","author":"A Angelucci","year":"2004","unstructured":"Angelucci, A. et al. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate 59, 157\u2013166 (2004).","journal-title":"Prostate"},{"key":"26143_CR66","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1158\/0008-5472.CAN-05-2816","volume":"66","author":"AC Khodavirdi","year":"2006","unstructured":"Khodavirdi, A. C. et al. Increased expression of osteopontin contributes to the progression of prostate cancer. Cancer Res 66, 883\u2013888 (2006).","journal-title":"Cancer Res"},{"key":"26143_CR67","first-page":"2271","volume":"5","author":"GN Thalmann","year":"1999","unstructured":"Thalmann, G. N. et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5, 2271\u20132277 (1999).","journal-title":"Clin Cancer Res"},{"key":"26143_CR68","doi-asserted-by":"publisher","first-page":"E1211","DOI":"10.1073\/pnas.1321347111","volume":"111","author":"X Xiao","year":"2014","unstructured":"Xiao, X. et al. M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7. Proc Natl Acad Sci USA 111, E1211\u20131220 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"26143_CR69","doi-asserted-by":"crossref","unstructured":"Zhang, Q.Z. et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28, 1856-1868 (2010).","DOI":"10.1002\/stem.503"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26143-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:30:08Z","timestamp":1671600608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26143-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26143"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26143-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"7 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7718"}}